Cylindrical prosthetic valves for the tricuspid position: prospects and limitations
https://doi.org/10.15825/1995-1191-2026-1-235-241
Abstract
Tricuspid valve (TV) replacement for primary regurgitation is a relatively rare procedure. Bioprosthetic valves are generally preferred because they do not require anticoagulant therapy and tend to degenerate more slowly in the tricuspid position than in the mitral or aortic positions; however, their durability remains limited, particularly in young patients. In contrast, mechanical prosthetic valves require rigorous anticoagulant therapy due to low blood flow in the right heart chambers. Prosthesis selection is especially challenging in cases of infective endocarditis with fibrous annular abscess. The aim of this study is to analyze experimental data on cylinder valves and to review the first clinical experiences reported worldwide. The development of new prosthesis models using inert and more durable materials may address current limitations of TV implants, optimize surgical techniques, and improve patient quality of life in the long-term.
About the Authors
S. I. BabenkoMoscow
A. S. Sachkov
Moscow
D. V. Britikov
Moscow
M. N. Sorkomov
Russian Federation
Maxim Sorkomov
135, Rublevskoe shosse, Moscow, 121552
Phone: (495) 414-78-49
R. R. Muratov
Moscow
I. S. Khayitmatov
Moscow
D. A. Titov
Moscow
References
1. Cox JL, Ad N, Myers K, Gharib M, Quijano RC. Tubular heart valves: a new tissue prosthesis design – preclinical evaluation of the 3F aortic bioprosthesis. J Thorac Cardiovasc Surg. 2005 Aug; 130 (2): 520–527.
2. Fallon AM, Goodchild TT, Cox JL, Matheny RG. In vivo remodeling potential of a novel bioprosthetic tricuspid valve in an ovine model. J Thorac Cardiovasc Surg. 2014 Jul; 148 (1): 333–340.e1.
3. Ropcke DM, Ilkjær C, Skov SN, Tjørnild MJ, Sørensen AV, Jensen H et al. Functional and Biomechanical Performance of Stentless Extracellular Matrix Tricuspid Tube Graft: An Acute Experimental Porcine Evaluation. Ann Thorac Surg. 2016 Jan; 101 (1): 125–132.
4. Hsu CPD, Mirzaa A, Mathenyb R, Ramaswamya S. Tricuspid Versus Mitral Performance of Cylindrical Porcine Small Intestinal Submucosa Valves. Structural Heart. 2021; 5 (1): 74. https://doi/org/10.1080/24748706.21.
5. Murala JSK, Sassalos P, Owens ST, Ohye RG. Porcine small intestine submucosa cylinder valve for mitral and tricuspid valve replacement. J Thorac Cardiovasc Surg. 2017 Sep; 154 (3): e57–e59. https://doi.org/10.1016/j.jtcvs.2017.03.129.
6. Veiseh O, Vegas AJ. Domesticating the foreign body response: Recent advances and applications. Adv Drug Deliv Rev. 2019 Apr; 144: 148–161.
7. Xue AH, Sarkeshik A, Boyd WD, Perry P. Tricuspid Valve Replacement Using CorMatrix® Extracellular Matrix Cylindrical Construct. CTSNet, Inc. Media. 2019. https://doi.org/10.25373/ctsnet.9793169.v2.
8. Kasravi M, Ahmadi A, Babajani A, Mazloomnejad R, Hatamnejad MR, Shariatzadeh S et al. Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine. Biomater Res. 2023 Feb 9; 27 (1): 10. doi: 10.1186/s40824-023-00348-z.
9. Gerdisch MW, Boyd WD, Harlan JL, Richardson JB Jr, Flack JE 3rd, Palafox BA et al. Early experience treating tricuspid valve endocarditis with a novel extracellular matrix cylinder reconstruction. J Thorac Cardiovasc Surg. 2014 Dec; 148 (6): 3042–3048.
10. Babenko SI, Muratov RM, Sorcomov MN. Current trends in the creation of cellfree allo- and xenotissues for reconstruction of heart structures. Russian Journal of Transplantology and Artificial Organs. 2021; 23 (1): 150–156. https://doi.org/10.15825/1995-1191-2021-1-150-156.
11. Britikov DV, Akatov VS, Chashchin IS, Zubko AV, Muratov RM. The evolution of approaches to the viability and devitalization of allografts and the development of a new decellularization method. Cellular modification of allografts. Clinical physiology of blood circulation. 2021; 2 (18): 118–127. doi: 10.24022/1814-6910-2021-18-2-128-138.
12. Padalino MA, Quarti A, Angeli E, Frigo AC, Vida VL, Pozzi M et al. Early and mid-term clinical experience with extracellular matrix scaffold for congenital cardiac and vascular reconstructive surgery: a multicentric Italian study. Interact Cardiovasc Thorac Surg. 2015 Jul; 21 (1):40–49. https://doi.org/10.1093/icvts/ivv076.
13. Zaidi AH, Nathan M, Emani S, Baird C, del Nido PJ, Gauvreau K et al. Preliminary experience with porcine intestinal submucosa (CorMatrix) for valve reconstruction in congenital heart disease: Histologic evaluation of explanted valves. J Thorac Cardiovasc Surg. 2014 Nov; 148 (5): 2216–2225.e1. https://doi.org/10.1016/j.jtcvs.2014.02.081.
14. Miyamoto S, Shinoka T, Kobayashi K. A Novel Template and Cylinder Bioprosthetic Atrioventricular Valve: An Ex Vivo Study. Ann Thorac Surg Short Rep. 2023 Sep 17; 1 (4): 642–646.
15. Charkiewicz-Szeremeta K, Matlak K, Garbowska M, Hirnle G, Kralisz P, Kocañda S, Hirnle T. Infective endocarditis of the tricuspid valve. Surgical treatment with pericardial cylinder implantation. Kardiochir Torakochirurgia Pol. 2023 Apr 3; 20 (1): 18–23. doi: 10.5114/kitp.2023.126094.
Review
For citations:
Babenko S.I., Sachkov A.S., Britikov D.V., Sorkomov M.N., Muratov R.R., Khayitmatov I.S., Titov D.A. Cylindrical prosthetic valves for the tricuspid position: prospects and limitations. Russian Journal of Transplantology and Artificial Organs. 2026;28(1):235-241. (In Russ.) https://doi.org/10.15825/1995-1191-2026-1-235-241
JATS XML


































